Should B-Type Natriuretic Peptide Be Measured Routinely to Guide the Diagnosis and Management of Chronic Heart Failure?
- 16 December 2003
- journal article
- editorial
- Published by Wolters Kluwer Health in Circulation
- Vol. 108 (24) , 2950-2953
- https://doi.org/10.1161/01.cir.0000109205.35813.8e
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Plasma B-Type Natriuretic Peptide Levels in Ambulatory Patients With Established Chronic Symptomatic Systolic Heart FailureCirculation, 2003
- Impact of age and sex on plasma natriuretic peptide levels in healthy adultsThe American Journal of Cardiology, 2002
- Rapid Measurement of B-Type Natriuretic Peptide in the Emergency Diagnosis of Heart FailureNew England Journal of Medicine, 2002
- The potential of brain natriuretic peptide as a biomarker for New York Heart Association class during the outpatient treatment of heart failureJournal of Cardiac Failure, 2002
- B-Type Natriuretic Peptide Levels: Diagnostic and Prognostic in Congestive Heart FailureCirculation, 2002
- Stability of B-type natriuretic peptide levels during exercise in patients with congestive heart failure: Implications for outpatient monitoring with B-type natriuretic peptideAmerican Heart Journal, 2002
- Plasma concentration of brain natriuretic peptide as a biochemical marker for the evaluation of right ventricular overload and mortality in chronic respiratory diseaseClinica Chimica Acta; International Journal of Clinical Chemistry, 2000
- Failure of plasma brain natriuretic peptide to identify left ventricular systolic dysfunction in the communityHeart, 2000
- Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrationsThe Lancet, 2000